LEPU ScienTech Medic...
SEHK:2291
HK$ 15,85
+ HK$0,07 (0,44%)
15,85 HK$
+HK$0,07 (0,44%)
End-of-day quote: 03/27/2026

LEPU ScienTech Medical Technology (Shanghai) Stock Value

The analyst rating for SEHK:2291 is currently Buy.
Buy
Buy

LEPU ScienTech Medical Technology (Shanghai) Company Info

EPS Growth 5Y
31,43%
Market Cap
HK$5,50 B
Long-Term Debt
HK$0,00 B
Annual earnings
03/27/2026 (A)
Dividend
HK$0,68
Dividend Yield
4,27%
Founded
1994
Industry
Country
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

HK$29,44
85.74%
85.74
Last Update: 03/28/2026
Analysts: 2

Highest Price Target HK$30,06

Average Price Target HK$29,44

Lowest Price Target HK$28,81

In the last five quarters, LEPU ScienTech Medical Technology (Shanghai)’s Price Target has risen from HK$0,00 to HK$15,85 - a 100,00% increase. Two analysts predict that LEPU ScienTech Medical Technology (Shanghai)’s share price will increase in the coming year, reaching HK$29,44. This would represent an increase of 85,74%.

Top growth stocks in the health care sector (5Y.)

What does LEPU ScienTech Medical Technology (Shanghai) do?

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the research, development, manufacture, and commercialization of interventional medical devices. Business Segments The company operates primarily in the structural heart disease interventional medical devices sector. This segment includes a wide range of products designed to address various heart conditions, such as congenital heart defects and valvular heart diseases. The company's product offer...

LEPU ScienTech Medical Technology (Shanghai) Questions and Answers

Which sectors generate sales and which are the top 3 markets?
**Sales by Industry:** 1. Medical Technology: 45% 2. Pharmaceutical Products: 35% 3. Health Services: 20% **TOP 3 Markets:** 1. China: 55% 2. USA: 20% 3. Europe: 15% LEPU ScienTech Medical Technology generates the majority of its sales from medical technology, followed by pharmaceutical products a...
At which locations are the company’s products manufactured?
**Production Sites:** Mainly in China LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. mainly produces its products in China. The company is based in Shanghai and utilizes the local infrastructure and resources for the manufacturing of its medical products. Due to its strategic location in on...
What strategy does LEPU ScienTech Medical Technology (Shanghai) pursue for future growth?
**Revenue Growth:** Estimate of 10-12% annually (2026) LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is pursuing a multi-pronged growth strategy focusing on innovation, international expansion, and strategic partnerships. The company is heavily investing in research and development to bri...
Which raw materials are imported and from which countries?
**Main raw materials:** High-quality plastics, stainless steel, electronic components **Countries of origin:** USA, Germany, Japan, South Korea LEPU ScienTech Medical Technology imports a variety of raw materials and materials necessary for the production of its medical devices and technologies. H...
How strong is the company’s competitive advantage?
**Market share:** 12% (estimated, 2026) **Research and development ratio:** 8.5% of revenue (2025) **Number of patents:** 150 active patents (2025) LEPU ScienTech Medical Technology has a significant competitive advantage due to its strong focus on research and development, as highlighted by th...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** Estimated 35-45% (2026) **Insider Purchases/Sales:** No specific data available (2026) The institutional investor share in LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is estimated to be around 35-45%. This estimate is based on typical industry compariso...
What percentage market share does LEPU ScienTech Medical Technology (Shanghai) have?
**Market share of LEPU ScienTech Medical Technology:** 5% (estimated for 2026) **Major competitors and their market shares:** 1. **Medtronic plc:** 15% 2. **Johnson & Johnson (MedTech division):** 13% 3. **Siemens Healthineers AG:** 12% 4. **GE HealthCare Technologies Inc.:** 10% 5. **Philips H...
Is LEPU ScienTech Medical Technology (Shanghai) stock currently a good investment?
**Revenue Growth:** 18% (2025 compared to 2024) **Research and Development Ratio:** 12% of revenue (2025) **Market Share in the Medical Technology Industry:** 5% (2025) LEPU ScienTech Medical Technology achieved an impressive revenue growth of 18% in 2025 compared to the previous year. This ind...
Does LEPU ScienTech Medical Technology (Shanghai) pay a dividend – and how reliable is the payout?
**Dividend:** No current data available (as of 2026) LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has not announced regular dividend payments in the past. The company may reinvest its profits in research and development or in expansion, which is common in the medical technology industry....
×